Ying Chen

Near-infrared luminescence high-contrast in vivo biomedical imaging

Ying Chen, Shangfeng Wang, Fan Zhang · Nature Reviews Bioengineering · 2023 · 458 citations · Full text

Vivo Biomedical Imaging, Engineering, Biomedical Imaging +4

2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

Ying Chen, Mrudula Pullambhatla, Catherine A. Foss et al. · Clinical Cancer Research · 2011 · 389 citations · Full text

Optically-controlled bacterial metabolite for cancer therapy

Diwei Zheng, Ying Chen, Zi-Hao Li et al. · Nature Communications · 2018 · 316 citations · Full text

Bacteria-Mediated Tumor Therapy Utilizing Photothermally-Controlled TNF-α Expression via Oral Administration

Jin‐Xuan Fan, Zi-Hao Li, Xinhua Liu et al. · Nano Letters · 2018 · 254 citations

Nanotherapeutics, Engineering, Microbial Pathogens +22

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

Shun Lü, Lin Wu, Hong Jian et al. · The Lancet Oncology · 2022 · 227 citations

Oncology, First Interim Results, Bevacizumab Biosimilar Ibi305 +10